Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Intra-Cellular Therapies, Inc.ITCI · Entity 81206 | Director | September 30, 2021 | October 04, 2021 |
| OPKO HEALTH, INC.OPK · Entity 4891 | Director | June 24, 2021 | June 25, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Intra-Cellular Therapies, Inc.
Report date September 30, 2021 · Filed October 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld by the Lerner Family Trust UAD 11/14/94 | 96,663 |
Reported balance
After 2021-09-30 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-09-30 · Grant · Acquired 402 · Balance 96,663 F1: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 11,430 |
Reported balance
Holding disclosure · report date 2021-09-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 11,430 |
Filing footnotes · ownership attribution and instrument terms
F1: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein.
OPKO HEALTH, INC.
Report date June 24, 2021 · Filed June 25, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.77 · Expires 2031-06-23 | Direct | 30,000 |
Reported balance
After 2021-06-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-24 · Grant · Acquired 30,000 · Balance 30,000 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SEQUENOM INC
Report date September 07, 2016 · Filed September 07, 2016
Section 16 reporting ended · disclosed 2016-09-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-09-07 transaction · row 1
1 source rowRow 1 · 2016-09-07 · Other · Disposed 27,383 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated July 26, 2016, among the Issuer, Laboratory Corporation of America Holdings, a Delaware corporation ("Parent"), and Savoy Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") in exchange for a cash consideration of $2.40 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger"). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.11 · Expires 2026-06-14 | Direct | 0 |
Reported balance
After 2016-09-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-09-07 · Disposition to issuer · Disposed 20,000 · Balance 0 F2: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.60 · Expires 2026-01-03 | Direct | 0 |
Reported balance
After 2016-09-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-09-07 · Disposition to issuer · Disposed 34,286 · Balance 0 F2: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated July 26, 2016, among the Issuer, Laboratory Corporation of America Holdings, a Delaware corporation ("Parent"), and Savoy Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Parent ("Purchaser") in exchange for a cash consideration of $2.40 per share, without interest, subject to any required withholding of taxes. Pursuant to the Merger Agreement, the Purchaser merged with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger").
F2: This option was cancelled in the Merger in exchange for a cash payment equal to $2.40 per share (without interest) minus the per share exercise price of the option. In connection with the Merger, vesting of the option was accelerated and the option became fully vested and exercisable effective immediately prior to the effective time of the Merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2021 Filed Oct 4, 2021 17:43 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 402 | $37.28 | $14,986.56 |
DisclosureSEC source: 0001209191-21-059104 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 96,663 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 16:47 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 367 | $40.82 | $14,980.94 |
DisclosureSEC source: 0001209191-21-045020 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 96,261 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 24, 2021 Filed Jun 25, 2021 12:45 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.77 | $0.00 |
DisclosureSEC source: 0001209191-21-043214 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-06-23 Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 16:23 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $43.45 | $0.00 |
DisclosureSEC source: 0001209191-21-042392 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-06-20 Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 17:31 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 442 | $33.93 | $14,997.06 |
DisclosureSEC source: 0001209191-21-024731 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 95,894 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 18:07 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 471 | $31.80 | $14,977.80 |
DisclosureSEC source: 0001209191-21-001511 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 95,452 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 16:17 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 584 | $25.66 | $14,985.44 |
DisclosureSEC source: 0001209191-20-053118 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 94,981 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 19:05 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 584 | $25.67 | $14,991.28 |
DisclosureSEC source: 0001209191-20-040684 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 94,397 Read SEC document |
| June 25, 2020 Filed Jun 26, 2020 12:53 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.68 | $0.00 |
DisclosureSEC source: 0001209191-20-039040 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-06-24 Read SEC document |
| May 27, 2020 Filed May 28, 2020 19:17 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $22.02 | $0.00 |
DisclosureSEC source: 0001209191-20-032747 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-05-26 Read SEC document |
| May 11, 2020 Filed May 13, 2020 17:20 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001209191-20-028898 · doc4.xml · derivative · entry 5 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2020-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All shares underlying this option have vested. Read SEC document |
| May 11, 2020 Filed May 13, 2020 17:20 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001209191-20-028898 · doc4.xml · derivative · entry 4 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2020-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All shares underlying this option have vested. Read SEC document |
| May 11, 2020 Filed May 13, 2020 17:20 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | SaleCommon Stock | 3,500 | $20.50 | $71,750.00 |
DisclosureSEC source: 0001209191-20-028898 · doc4.xml · nonDerivative · entry 3 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 93,813 F2 · kind: The proceeds from this sale will be used primarily to cover the reporting person's tax liability arising from the exercise of options. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.50 to $20.51 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above. F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| May 11, 2020 Filed May 13, 2020 17:20 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | Exercise / conversionCommon Stock | 25,000 | $2.74 | $68,500.00 |
DisclosureSEC source: 0001209191-20-028898 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 97,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 18:01 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 975 | $15.37 | $14,985.75 |
DisclosureSEC source: 0001209191-20-022760 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 72,313 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| December 31, 2019 Filed Jan 16, 2020 18:13 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 400 | $34.31 | $13,724.00 |
DisclosureSEC source: 0001209191-20-003756 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 71,338 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| September 30, 2019 Filed Oct 2, 2019 17:35 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 1,840 | $7.47 | $13,744.80 |
DisclosureSEC source: 0001209191-19-051857 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 70,938 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 17:12 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 1,059 | $12.98 | $13,745.82 |
DisclosureSEC source: 0001209191-19-040436 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 69,098 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 25, 2019 Filed Jun 26, 2019 16:43 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001209191-19-039114 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-06-24 Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 10:40 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001209191-19-038353 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-06-19 Read SEC document |
| March 31, 2019 Filed Apr 2, 2019 18:52 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 1,128 | $12.18 | $13,739.04 |
DisclosureSEC source: 0001209191-19-022712 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 68,039 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 20:11 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 1,207 | $11.39 | $13,747.73 |
DisclosureSEC source: 0001209191-19-001532 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,430 Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 16:33 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001209191-18-056061 · doc4.xml · derivative · entry 3 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2018-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: All shares underlying this option have vested. F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| October 22, 2018 Filed Oct 24, 2018 16:33 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | Exercise / conversionCommon Stock | 12,500 | $1.50 | $18,750.00 |
DisclosureSEC source: 0001209191-18-056061 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 66,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| September 30, 2018 Filed Oct 2, 2018 20:11 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 633 | $21.70 | $13,736.10 |
DisclosureSEC source: 0001209191-18-053530 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 54,411 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 16:27 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 778 | $17.67 | $13,747.26 |
DisclosureSEC source: 0001209191-18-041086 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 53,778 F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| June 21, 2018 Filed Jun 22, 2018 20:14 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-18-039175 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-20 Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 16:45 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $20.39 | $0.00 |
DisclosureSEC source: 0001209191-18-038786 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-17 Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:13 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0001209191-18-030187 · doc4.xml · derivative · entry 7 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2018-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vested as follows: 8,333 shares on each of June 9, 2012 and June 9, 2013, and 8,334 shares on June 9, 2014. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:13 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.43 | $0.00 |
DisclosureSEC source: 0001209191-18-030187 · doc4.xml · derivative · entry 6 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2018-06-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:13 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 12,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030187 · doc4.xml · nonDerivative · entry 4 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 178,881 F3 · ownership.nature: Securites held by the Lerner Family Trust, Richard A & Nicola G Lerner Trustees U/A Dated 11/14/1994. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:13 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 12,709 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-030187 · doc4.xml · nonDerivative · entry 3 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:13 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Tax withholdingCommon Stock | 32,291 | $4.78 | $154,350.98 |
DisclosureSEC source: 0001209191-18-030187 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,709 F1 · shares: Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. No shares of Common Stock were sold by the reporting person in connection with this transaction. The reporting person has retained the net number of shares issued upon the exercise of the option (12,709 shares). F2 · price: Closing market price of the Company's common stock on the transaction date. Read SEC document |
| May 14, 2018 Filed May 15, 2018 20:13 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Exercise / conversionCommon Stock | 45,000 | $3.43 | $154,350.00 |
DisclosureSEC source: 0001209191-18-030187 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2018 Filed Apr 3, 2018 16:33 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 653 | $21.05 | $13,745.65 |
DisclosureSEC source: 0001209191-18-022986 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,223 Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 18:01 UTC Amendment | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 949 | $14.48 | $13,741.52 |
DisclosureSEC source: 0001209191-18-001224 · doc4a.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,570 Read SEC document |
| December 29, 2017 Filed Jan 3, 2018 16:29 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | PurchaseCommon Stock | 949 | $14.48 | $13,741.52 |
DisclosureSEC source: 0001209191-18-000892 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,570 Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 16:52 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001209191-17-065461 · doc4.xml · derivative · entry 4 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2017-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All shares underlying this option have vested. F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 16:52 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | SaleCommon Stock | 7,000 | $15.09 | $105,630.00 |
DisclosureSEC source: 0001209191-17-065461 · doc4.xml · nonDerivative · entry 3 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 53,000 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017. The proceeds from this sale will be used primarily to cover the reporting person's tax liability arising from the exercise of the option. F3 · price: The shares were sold at prices ranging from $14.97 to $15.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| December 11, 2017 Filed Dec 13, 2017 16:52 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | Exercise / conversionCommon Stock | 12,500 | $1.50 | $18,750.00 |
DisclosureSEC source: 0001209191-17-065461 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by the Lerner Family Trust UAD 11/14/94 Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Dr. Lerner may be deemed to beneficially own securities held by the Lerner Family Trust UAD 11/14/94 (the "Lerner Family Trust"). Dr. Lerner disclaims beneficial ownership of securities held by the Lerner Family Trust except to the extent of his pecuniary interest therein. Read SEC document |
| September 29, 2017 Filed Oct 3, 2017 18:14 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 871 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-055375 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,621 Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 18:29 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 1,107 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-043672 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,750 Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 16:20 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $12.45 | $0.00 |
DisclosureSEC source: 0001209191-17-042285 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-06-27 Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 20:21 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001209191-17-040511 · doc4.xml · derivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-06-14 Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 11:16 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 3,298 | $6.32 | $20,843.36 |
DisclosureSEC source: 0001209191-17-037994 · doc4.xml · nonDerivative · entry 3 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 166,172 F1 · ownership.nature: Securites held by the Lerner Family Trust, Richard A & Nicola G Lerner Trustees U/A Dated 11/14/1994. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 11:16 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 500 | $6.32 | $3,157.50 |
DisclosureSEC source: 0001209191-17-037994 · doc4.xml · nonDerivative · entry 2 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 162,874 F1 · ownership.nature: Securites held by the Lerner Family Trust, Richard A & Nicola G Lerner Trustees U/A Dated 11/14/1994. Read SEC document |
| June 05, 2017 Filed Jun 6, 2017 11:16 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | PurchaseCommon Stock | 6,202 | $6.31 | $39,134.62 |
DisclosureSEC source: 0001209191-17-037994 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 162,374 F1 · ownership.nature: Securites held by the Lerner Family Trust, Richard A & Nicola G Lerner Trustees U/A Dated 11/14/1994. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 16:51 UTC | Intra-Cellular Therapies, Inc. ITCI · Entity 81206 | GrantCommon Stock | 846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-024949 · doc4.xml · nonDerivative · entry 1 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,643 Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 22:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001209191-17-020903 · doc4.xml · derivative · entry 6 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 22:30 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GiftCommon Stock | 44,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-020903 · doc4.xml · nonDerivative · entry 4 LERNER RICHARD A · CIK 0001316274 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 156,172 F3 · ownership.nature: Securites held by the Lerner Family Trust, Richard A & Nicola G Lerner Trustees U/A Dated 11/14/1994. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.